Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/Y-MABS-THERAPEUTICS-INC-46288936/news/Y-mAbs-Therapeutics-mAbs-Announces-Priorit-Review-of-BLA-for-DANELZA-naxitamab-gqgk-in-China-36423297/?utm_source=whatsapp&utm_medium=social&utm_campaign=share